MedPath

New Type of a Pancreaticojejunostomy

Phase 1
Conditions
Pancreaticojejunostomy After Pancreatic Head Resection
Registration Number
NCT00471627
Lead Sponsor
Tampere University
Brief Summary

Previously we have demonstrated in animal experiments,that pancreas is extremely vulnerable to handling, reacting with the development of pancreatitis. In human pancreatic surgery, post-operative pancreatitis mediates many other post-operative complications. A new anastomosis was developed to diminish the injury, as being without any stitches going through the pancreas. The aims were to study up to 30 patients as phase one study, with an interim analysis in this open uncontrolled trial after the first few patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients scheduled to undergo peancreatic head resection
Read More
Exclusion Criteria
  • Those who refuse from the study
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Pancreatic fistula, other complicationsOne year from operation
Secondary Outcome Measures
NameTimeMethod
Patency of the pancreaticojejunostomyOne year

Trial Locations

Locations (1)

Tampere University Hospital

🇫🇮

Tampere, Finland

© Copyright 2025. All Rights Reserved by MedPath